Domain & survey items | Â | Response options (n) % | ||||
---|---|---|---|---|---|---|
Treatment – role | Student groups | strongly disagree | disagree | uncertain | agree | strongly agree |
My role in managing patients with FM is to provide symptom relief over functional gains | PT/OT †| (2) 3% | (13) 21% | (23) 38% | (15) 25% | (8) 13% |
 | DC | (1) 1% | (12) 9% | (34) 24% | (52) 37% | (43) 30% |
 | ND †| (1) 1% | (5) 4% | (25) 19% | (45) 34% | (56) 42% |
My role in managing patients with FM is to promote functional gains over symptom relief | PT/OT †|  |  | (3) 5% | (12) 20% | (46) 75% |
 | DC †| (1) 1% | (7) 5% | (22) 16% | (56) 39% | (56) 39% |
 | ND |  |  | (17) 13% | (38) 29% | (76) 57% |
My role in managing patients with FM is to minimize involvement as I have little to offer | PT/OT | (44) 72% | (14) 23% | (3) 5% | Â | Â |
 | DC †| (61) 43% | (47) 33% | (25) 18% | (5) 4% | (3) 2% |
 | ND †| (111) 84% | (8) 6% | (7) 5% | (4) 3% |  |
My role in managing patients with FM is to refer for further investigations to identify cause | PT/OT †| (14) 23% | (16) 26% | (19) 31% | (11) 18% | (1) 2% |
 | DC †| (4) 3% | (16) 11% | (49) 35% | (47) 33% | (26) 18% |
 | ND †| (19) 14% | (34) 26% | (40) 31% | (18) 14% | (18) 14% |
Treatment – confidence |  |  |  |  |  |  |
Patients with FM are difficult to manage | PT/OT †| (3) 5% | (5) 8% | (27) 44% | (24) 39% | (2) 3% |
 | DC †|  | (7) 5% | (33) 23% | (81) 57% | (21) 15% |
 | ND †| (1) 1% | (22) 17% | (43) 32% | (53) 40% | (14) 11% |
Exercise can be harmful to patients with FM | PT/OT †| (25) 41% | (25) 41% | (3) 5% | (4) 7% | (4) 7% |
 | DC | (41) 29% | (74) 52% | (20) 14% | (7) 5% |  |
 | ND †| (24) 18% | (84) 63% | (19) 14% | (5) 4% |  |
There are effective treatments for FM | PT/OT †|  | (1) 2% | (17) 28% | (42) 69% | (1) 2% |
 | DC †| (3) 2% | (30) 21% | (65) 46% | (43) 30% | (1) 1% |
 | ND †| (2) 2% | (9) 7% | (16) 12% | (71) 53% | (33) 25% |
I am confident that I have the clinical skills to effectively manage patients diagnosed with FM | PT/OT | Â | (12) 20% | (19) 31% | (28) 46% | (2) 3% |
 | DC †| (3) 2% | (29) 20% | (53) 37% | (53) 37% | (4) 3% |
 | ND †| (1) 1% | (9) 7% | (26) 20% | (62) 47% | (34) 26% |